Truist Securities Starts RayzeBio (RYZB) at Buy, 'favorable risk/reward'
Tweet Send to a Friend
(Updated - October 10, 2023 6:04 AM EDT)
Truist Securities analyst Robyn Karnauskas initiates coverage on RayzeBio (NASDAQ: RYZB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Robyn Karnauskas initiates coverage on RayzeBio (NASDAQ: RYZB) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
